Apellis Pharmaceuticals, Inc. (APLS): IPOs News

APLS – Opens for trading at $14.50 after pricing IPO at $14.


Key Facts Surrounding This News Item


  • APLS had returned 0.00% year-to-date leading up to today’s news, versus a +17.57% return from the benchmark S&P 500 during the same period.

More Info About Apellis Pharmaceuticals, Inc. (APLS)


Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of therapeutic compounds for autoimmune and inflammatory diseases. The company was founded in 2009 and is based in Crestwood, Kentucky. View our full APLS ticker page with ratings, news, and more.

APLS at a Glance

APLS Current POWR Rating™
Overall POWR Rating™
APLS Current Price $13.79 0.22%
More APLS Ratings, Data, and News

APLS Price Reaction

The day of this event (Nov. 9, 2017)
APLS Closing Price$14.03 N/A%
APLS Volume2,297,600
N/A% from avg
Leading up to this event
APLS 1-mo returnN/A%
After this event
APLS 1-day returnN/A%
APLS 3-day returnN/A%
APLS 5-day returnN/A%

APLS Price Chart



More Apellis Pharmaceuticals, Inc. (APLS) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All APLS News
Page generated in 0.7151 seconds.